JP Morgan Chase’s Colgate-Palmolive CL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | – | Sell |
-160,000
| Closed | -$13.7M | – | 7776 |
|
|
2026
Q1 | $13.7M | Buy |
+160,000
| New | +$14.3M | ﹤0.01% | 2398 |
|
|
2025
Q2 | – | Sell |
-6,800
| Closed | -$637K | – | 7139 |
|
|
2025
Q1 | $637K | Buy |
+6,800
| New | +$609K | ﹤0.01% | 4631 |
|
|
2024
Q4 | – | Sell |
-3,100
| Closed | -$322K | – | 7424 |
|
|
2024
Q3 | $322K | Buy |
+3,100
| New | +$316K | ﹤0.01% | 5166 |
|
|
2024
Q2 | – | Sell |
-140,000
| Closed | -$12.6M | – | 7393 |
|
|
2024
Q1 | $12.6M | Buy |
+140,000
| New | +$11.9M | ﹤0.01% | 2276 |
|
|
2023
Q1 | – | Sell |
-263,400
| Closed | -$20.8M | – | 6746 |
|
|
2022
Q4 | $20.8M | Sell |
263,400
-126,100
| -32% | -$9.45M | ﹤0.01% | 1646 |
|
|
2022
Q3 | $27.4M | Buy |
389,500
+196,000
| +101% | +$15.4M | ﹤0.01% | 1375 |
|
|
2022
Q2 | $15.5M | Buy |
193,500
+68,100
| +54% | +$5.33M | ﹤0.01% | 1833 |
|
|
2022
Q1 | $9.51M | Buy |
125,400
+102,900
| +457% | +$8.15M | ﹤0.01% | 2423 |
|
|
2021
Q4 | $1.92M | Buy |
+22,500
| New | +$1.76M | ﹤0.01% | 3899 |
|
|
2020
Q1 | – | Sell |
-107,500
| Closed | -$7.4M | – | 5340 |
|
|
2019
Q4 | $7.4M | Hold |
107,500
| – | – | ﹤0.01% | 2378 |
|
|
2019
Q3 | $7.9M | Hold |
107,500
| – | – | ﹤0.01% | 2322 |
|
|
2019
Q2 | $7.75M | Hold |
107,500
| – | – | ﹤0.01% | 2294 |
|
|
2019
Q1 | $7.37M | Sell |
107,500
-65,100
| -38% | -$4.21M | ﹤0.01% | 2294 |
|
|
2018
Q4 | $10.3M | Buy |
172,600
+112,100
| +185% | +$7.01M | ﹤0.01% | 1991 |
|
|
2018
Q3 | $4.05M | Hold |
60,500
| – | – | ﹤0.01% | 2912 |
|
|
2018
Q2 | $3.92M | Hold |
60,500
| – | – | ﹤0.01% | 2872 |
|
|
2018
Q1 | $4.34M | Buy |
+60,500
| New | +$4.35M | ﹤0.01% | 2702 |
|
|
2017
Q3 | – | Sell |
-1,204,000
| Closed | -$89.3M | – | 4981 |
|
|
2017
Q2 | $89.3M | Buy |
1,204,000
+18,300
| +2% | +$1.36M | 0.02% | 661 |
|
|
2017
Q1 | $86.8M | Buy |
+1,185,700
| New | +$83M | 0.02% | 676 |
|
|
2015
Q3 | – | Sell |
-100,000
| Closed | -$6.54M | – | 3934 |
|
|
2015
Q2 | $6.54M | Buy |
100,000
+95,300
| +2,028% | +$6.46M | ﹤0.01% | 2229 |
|
|
2015
Q1 | $326K | Buy |
4,700
+3,100
| +194% | +$214K | ﹤0.01% | 3674 |
|
|
2014
Q4 | $111K | Sell |
1,600
-34,000
| -96% | -$2.3M | ﹤0.01% | 4094 |
|
|
2014
Q3 | $2.32M | Buy |
+35,600
| New | +$2.35M | ﹤0.01% | 2831 |
|
Other funds holding CL
JP Morgan Chase's CL Position: Q2 2026 in Review
JP Morgan Chase reduced its Colgate-Palmolive (CL) stake by 6.6% in Q2 2026, selling an estimated $21M and leaving 3,395,281 shares worth $314M. The position accounts for 0.02% of the portfolio, ranked #601.
JP Morgan Chase first reported a position in CL in Q2 2013 and has held it in 53 quarters since. The position peaked at $856M in Q2 2023. 2,017 funds tracked by Wall St. Rank hold CL as of Q2 2026.
- JP Morgan Chase held 3,395,281 shares of Colgate-Palmolive worth $314M as of Q2 2026.
- JP Morgan Chase sold 240,319 Colgate-Palmolive shares in Q2 2026, an estimated $21M.
- Colgate-Palmolive made up 0.02% of JP Morgan Chase's portfolio in Q2 2026, its #601 holding.
- JP Morgan Chase first reported a position in Colgate-Palmolive in Q2 2013 and has held it in 53 quarters since.
- JP Morgan Chase's Colgate-Palmolive position peaked at $856M in Q2 2023.
- 2,017 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q2 2026.
Based on JP Morgan Chase's 13F filing for Q2 2026, filed 12 Aug 2026.